SusanCrawfordMD

PubMed

• Influence of maternal obesity and metabolic and vascular mediators in twin-twin transfusion syndrome.
  Starnes, S. E.,Nardi, F.,Fitchev, P.,Plunkett, B. A.,Thorpe, C.,Wang, C. H.,Vogler, C.,Crawford, S. E.> ;Reprod Biol. 2019 May 31
• DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130.
  Nardi, F.,Franco, O. E.,Fitchev, P.,Morales, A.,Vickman, R. E.,Hayward, S. W.,Crawford, S. E.> ;Sci Rep. 2019 Mar 01
• (rho0) Cells Reduced Mitochondrial Function Mediates Transcriptomic Alterations Associated with Cancer
  Hani Nakhoul, Susan E Crawford> ;Rapamycin Press. 2018 Jan 19
• 16 citations
  Effectiveness of a Multicomponent Sun Protection Program for Young Children: A Randomized Clinical Trial.
  Byron K. Ho, Katie Reidy, Imelda Huerta, Kimberley Dilley, Susan Crawford, Brittney A. Hultgren, Kimberly A. Mallett, Rob Turrisi, June K. Robinson> ;JAMA Pediatrics. 2016 Apr 1
• Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1.
  Tong, X.,Mirzoeva, S.,Veliceasa, D.,Bridgeman, B. B.,Fitchev, P.,Cornwell, M. L.,Crawford, S. E.,Pelling, J. C.,Volpert, O. V.> ;Oncotarget. 2014 Dec 20
• Peritumoral Expression of Adipokines and Fatty Acids in Breast Cancer
  Susan E Crawford, Katharine A Yao> ;Springer. 2013 Sep 20
• Loss of the cytoskeletal protein pdlim7 predisposes mice to heart defects and hemostatic dysfunction.
  Krcmery, J.,Gupta, R.,Sadleir, R. W.,Ahrens, M. J.,Misener, S.,Kamide, C.,Fitchev, P.,Losordo, D. W.,Crawford, S. E.,Simon, H. G.> ;PLoS ONE. 2013 Nov 28
• PEDF & stem cells: niche vs. nurture.
  Fitchev, P.,Chung, C.,Plunkett, B. A.,Brendler, C. B.,Crawford, S. E.> ;Curr Drug Deliv. 2013 Mar 23
• Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
  Crawford, S. E.,David, M. Z.,Glikman, D.,King, K. J.,Boyle-Vavra, S.,Daum, R. S.> ;J Am Board Fam Med. 2009 Nov 10
• Join now to see all

Journal Articles

• Tyrosine Kinase Inhibitor Therapy Prescribed for Non‐Urologic Diseases Can Modify PSA Titers in Urology Patients  
  Susan Crawford, MD, The Prostate